Home / Benralizumab / Belgium
BE ATC R03DX10 · updated 2 Nov 2026
Benralizumab shortage in Belgium
Is there a Benralizumab shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Benralizumab product is reported short in Belgium, the first since 1 Jan 2026. The company estimate for the return is 31 Dec 2026. Main reason: other.
Not reported short in any other country we track. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Fasenra 30 mg (Orifarm) inj. sol. s.c. pre-filled pen 1 ml | AstraZeneca | 1 Jan 2026 | 31 Dec 2026 | Other Other reason |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.